Welcome to our dedicated page for Virtuix Holdings SEC filings (Ticker: VTIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Virtuix Holdings Inc. (VTIX) SEC filings document the company’s public reporting as a Nasdaq-listed emerging growth company focused on AI-driven full-body simulation systems. Its filings identify common stock trading on the Nasdaq Global Market under VTIX and provide regulatory detail behind company updates about Omni One, defense applications, operating results, governance, and financing arrangements.
Quarterly reports are especially relevant for Virtuix because they include revenue recognition policies, contract descriptions, financial statements, risk language, and going-concern disclosure. The company’s filings state that contracts typically include product sales, installation services, support programs, or digital playtime credits, and that most contracts involve transferring or installing physical goods.
Virtuix 8-K filings report material events such as operating results, business development updates, auditor changes, board matters, and warrant amendments. Proxy materials provide stockholder meeting information and governance disclosures. Notices of late filing, amended quarterly reports, and other periodic filings give additional context when the timing or content of reports changes.
For VTIX, useful filing review areas include Form 10-Q reports, 8-K event disclosures, proxy statements, capital structure items, revenue policies, auditor transitions, and any Form 4 insider transaction reports filed for company insiders. Together, these filings show how Virtuix presents its business, obligations, and risk disclosures in the SEC record.
Virtuix Holdings Inc. entered into amendments with Streeterville Capital, LLC to change the exercise price on certain existing warrants for Class A Common Stock during a previously established reduced-price period. The exercise price, which had been set at $4.00 per warrant share, is now $3.00 per warrant share while this Reduced Exercise Price Period remains in effect.
The warrants continue to expire on July 27, 2026, and all other terms remain unchanged. Virtuix may end the Reduced Exercise Price Period at any time by giving two trading days’ prior written notice, after which the exercise price reverts to the Nasdaq Valuation Price defined in the original warrants.
Virtuix Holdings Inc. reported fiscal 2026 results showing early scale but continued losses as it expands AI-driven VR across consumer, defense, and enterprise markets. Net sales for the year ended March 31, 2026 rose 18% to $4.3 million, driven mainly by new Omni One sales and a strong 2025 holiday season. Gross profit improved to $1.0 million from a gross loss, and gross margin turned positive at 25%, helped by a higher Omni One price, lower unit overhead, and completion of discounted crowdfunding units.
Total operating expenses fell 19% to $11.4 million, yet net loss widened to $(16.8) million from $(14.6) million, largely due to about $6.4 million of non-cash, non-operating items, including interest, debt-discount amortization, and a one-time warrant modification. Cash and equivalents increased sharply to $9.5 million as of March 31, 2026 from $0.5 million a year earlier, supported by warrant exercises and convertible note financing.
Strategically, Virtuix listed on Nasdaq under VTIX, launched Omni One for Quest under Meta’s “Made for Meta” program, and expanded sales into Europe and Canada. In defense, it secured an AFWERX SBIR Phase I award with the U.S. Air Force, a lead integrator role with the U.S. Marine Corps through KBR, a Cooperative R&D Agreement with the U.S. Navy, and sales to U.S. Army and Air Force institutions. Management highlighted a multi-use strategy targeting high-volume consumer revenue plus higher-margin defense and enterprise contracts with recurring software income.
Virtuix Holdings Inc. filed its annual report describing operations and financial results for the year ended March 31, 2026. The company makes Omni-branded omni-directional treadmills and is scaling its consumer Omni One system while developing its defense-focused Virtual Terrain Walk (VTW) simulation platform.
Net revenue grew 18% to $4.25 million, driven mainly by Omni One sales, and gross margin improved from -6% to 25% as pricing increased and manufacturing overhead per unit fell. However, Virtuix reported a net loss of $16.8 million and negative Adjusted EBITDA of $8.0 million, extending its accumulated deficit to $79.3 million.
To fund operations, Virtuix executed multiple debt, warrant and equity arrangements with Streeterville Capital and others, including an Equity Purchase Agreement of up to $50 million and warrant exercises. Cash on hand was $9.47 million, but management acknowledges substantial doubt about the company’s ability to continue as a going concern without additional financing, despite subsequent capital raises after year-end.
Virtuix Holdings Inc. is registering the resale of 34,213,618 shares of its Class A common stock by identified stockholders in connection with its direct listing on the Nasdaq Global Market. This Sticker Supplement dated June 2, 2026 modifies the Prospectus and adds disclosures about warrant amendments.
The Company disclosed amendments dated June 1, 2026 to warrants held by Streeterville Capital, LLC that reduce the exercise price to $4.00 per Warrant share and extend the Reduced Exercise Price Period through the warrants' expiration on July 27, 2026. The Company may terminate the Reduced Exercise Price Period with two trading days' prior written notice, whereupon the exercise price will revert to the Nasdaq Valuation Price.
Virtuix Holdings Inc. amended multiple warrants held by Streeterville Capital to buy Class A common stock. The amendments reduce the exercise price from $6.00 to $4.00 per warrant share and extend the reduced pricing period through the warrants’ July 27, 2026 expiration, although the company can end this period with two trading days’ notice, after which pricing reverts to the Nasdaq Valuation Price in the original warrants.
The company also announced it will hold a conference call on June 25, 2026 at 8:30 a.m. Eastern time to discuss results for the fiscal year ended March 31, 2026 and provide a business update.
Virtuix Holdings Inc. entered a new financing arrangement by exchanging three secured convertible notes held by Streeterville Capital for an unsecured Pre-Paid Purchase with an original principal of $3,471,923 bearing 6% interest, compounded daily. Streeterville can apply this balance to purchase Class A common shares at a fixed price, subject to adjustment after defined trigger events and a 9.99% beneficial ownership cap. The instrument carries prepayment premiums ranging from 120% to 105% and default interest of 15%, with customary covenants and default remedies.
Separately, Virtuix highlighted two business developments: a Rutgers University collaboration using its Omni One platform for AI-assisted neurodivergent therapy research, and a U.S. Air Force AFWERX SBIR Phase I selection to advance its Virtual Terrain Walk mission-planning system, reinforcing opportunities in healthcare and defense markets.
Virtuix Holdings Inc. registers resale by selling stockholders of up to 25,307,961 shares of Class A common stock pursuant to this prospectus, including up to 25,000,000 shares issuable to Streeterville Capital, LLC. The prospectus states the Company will not receive proceeds from resales and includes a May 7, 2026 reference price of $3.97 per share.
The registration covers shares issued or issuable to three selling holders and describes an associated Pre-Paid Purchase equity financing arrangement with Streeterville that contemplates up to $50,000,000 of prepaid advances and related warrants, subject to ownership limits including a 9.99% beneficial ownership cap and Nasdaq rule constraints.
Virtuix Holdings Inc. has filed an S-1 registering up to 25,307,961 shares of Class A common stock for resale by existing selling stockholders, not for sale by the company, so Virtuix will not receive proceeds from these resales. The bulk of these shares, up to 25,000,000, are issuable to Streeterville Capital under a prepaid equity financing facility of up to $50,000,000. Virtuix develops “Omni” omni-directional VR treadmills and has generated over $20 million in cumulative sales, including over $4 million from the first 1,800 Omni One units shipped by September 2025. The company is an emerging growth, smaller reporting, and controlled company and highlights significant risks, including continued losses, supply chain concentration in China and Taiwan, competitive VR markets, and extensive regulatory and data-privacy obligations.
Virtuix Holdings Inc. director and Chief Executive Officer Jan Roger Goetgeluk sold 20,279 shares of Class A common stock in an open-market transaction at $3.58 per share on May 6, 2026. After this sale, he directly holds 4,000,000 shares. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted before the company’s direct listing, indicating the sale was scheduled in advance rather than timed discretionarily.